Participant may continue taking the study drugs for as long as the doctor thinks it is in participant's best interest. Participant will no longer be able to take the study drugs if the disease gets worse, intolerable side effects occur, participant develops new health problems, participant becomes pregnant, or participant does not follow the instructions on the study.